Can soluble (regular) insulin be kept at room temperature after opening if no refrigerator is available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Soluble Insulin Be Kept at Room Temperature After Opening?

Yes, soluble (regular) insulin can and should be kept at room temperature after opening if no refrigerator is available, and this is actually the recommended practice to reduce injection site pain and prevent lipodystrophy. 1

Storage Guidelines for Opened Insulin

Room Temperature Storage is Acceptable and Preferred

  • Once opened, insulin vials and pens should be stored at ambient temperatures (15 to 30°C or 59 to 86°F) away from direct sunlight until the manufacturer's expiration date, typically 28 days. 1

  • The American Diabetes Association explicitly states that insulin in use may be kept at room temperature to limit local irritation at the injection site, which may occur when cold insulin is used. 1

  • Insulin should be allowed to come to room temperature by leaving it out of the refrigerator for 30 to 60 minutes before injection, as cold insulin can be painful and contribute to lipodystrophy development. 1

Maximum Duration and Temperature Limits

  • Most manufacturers recommend that opened insulin can be stored at room temperature for up to 28-42 days, depending on the specific product. 2

  • Extreme temperatures (<36°F or >86°F, <2°C or >30°C) should be avoided to prevent loss of potency, clumping, frosting, or precipitation. 1

  • If room temperatures exceed 30°C (86°F), insulin in current use should be stored in a refrigerator and allowed to warm up before injection. 1

Evidence Supporting Extended Room Temperature Storage

Research on Insulin Stability

  • Laboratory studies demonstrate that human short-acting insulin (SAI), intermediate-acting insulin (IAI), and mixed insulin (MI) maintain potency at temperatures ranging between 28.9°C and 37°C for up to four months without clinically relevant loss of insulin activity. 3

  • Pharmaceutical company data from Novo Nordisk shows that after six months at 25°C, loss of SAI activity was only 3.2% to 3.5%, and after two months at 37°C, loss was 5.7%. 3

  • A 2021 study found that insulin pens stored at 37°C for 28 days showed no statistically significant differences in potency compared to refrigerated insulin, with percentage amounts remaining at 98.5-101.1% of control values. 4

  • Oscillating temperatures between 25°C and 37°C for up to three months result in no loss of insulin activity for SAI, IAI, and MI. 3

Critical Monitoring Requirements

Daily Inspection Protocol

  • Before each use, inspect the insulin bottle for changes including clumping, frosting, precipitation, or change in clarity or color that may signify loss of potency. 1

  • Visual examination should reveal rapid- and short-acting insulins (including regular insulin) to be clear; any cloudiness indicates potential degradation. 1

  • Patients should relate any unexplained increase in blood glucose to possible reductions in insulin potency and replace questionable vials. 1

Potency Considerations

  • Although an expiration date is stamped on each vial, loss in potency may occur after the bottle has been in use for >1 month, especially if stored at room temperature. 1

  • Storage at 32°C and 37°C showed 14-18% decrease in potency of insulin on the 28th day, though this was primarily observed in controlled laboratory conditions. 5

Practical Recommendations for Resource-Limited Settings

Alternative Cooling Methods

  • In settings without refrigeration, simple cooling devices such as unglazed clay pots can maintain temperatures between 25°C and 27°C, with insulin showing comparable glucose-lowering effects to refrigerator-stored insulin. 3

  • Homemade evaporative cooling wallets made from acrylate polymer beads demonstrate 71% cooling efficacy, comparable to commercial FRIO wallets (73%), and are cost-effective alternatives for resource-limited settings. 6

  • Patients should use cooler packs or insulated bags if bringing insulin outside in hot conditions. 1

Common Pitfalls to Avoid

  • Never freeze insulin; frozen insulin must be discarded as freezing destroys insulin potency. 1, 2

  • Do not inject cold insulin directly from the refrigerator, as this causes pain and may contribute to lipodystrophy. 1, 7

  • Avoid exposure to direct heat, light, or excessive agitation, which can degrade insulin. 1

  • Always maintain a spare bottle of each insulin type in case of suspected potency loss. 1

  • Do not store opened insulin pens in the refrigerator; they must be kept at room temperature. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thermal stability and storage of human insulin.

The Cochrane database of systematic reviews, 2023

Research

The Effect of Temperature on the Stability of In-Use Insulin Pens.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2021

Research

Effect of temperature on the potency & pharmacological action of insulin.

The Indian journal of medical research, 2009

Guideline

Insulin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.